Competing Interests
Dr. Downar has received research support from the Arrell Family Foundation, Brain Canada, the Buchan Family Foundation, the Canadian Biomarker Integration Network in Depression, the Canadian Institutes of Health Research (CIHR), the Edgestone Foundation, the Klarman Family Foundation, NIMH, and the Ontario Brain Institute; he has received travel stipends from Lundbeck and ANT Neuro; he has served as an adviser for BrainCheck, Restorative Brain Clinics, and TMS Neuro Solutions. Dr. Vila-Rodriguez has received research support from Brain Canada, CIHR, the Michael Smith Foundation for Health Research, and the Vancouver Coastal Health Research Institute, and he has participated on an advisory board for Janssen. Dr. Noda has received a Grant-in-Aid for Young Scientists (KAKENHI) and a research grant from the Japan Agency for Medical Research and Development; and he has received an investigator-initiated clinical study grant from Teijin Pharma Limited and research grants from the Daiichi Sankyo Scholarship Donation Program, the Health Science Center Foundation, the Japan Health Foundation, the Meiji Yasuda Mental Health Foundation, the Mitsui Life Social Welfare Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Senshin Medical Research Foundation, and the Takeda Science Foundation. Dr. Giacobbe has received research support from the CIHR and NIH; he has served as an unpaid consultant for St. Jude Medical, and he has served on advisory boards for Bristol-Myers Squibb and Janssen. Dr. Kennedy has received research support or consulting or speaking honoraria from Abbott, Alkermes, Allergan, Brain Canada, Bristol-Myers Squibb, CIHR, Janssen, Lundbeck, the Lundbeck Institute, the Ontario Brain Institute, the Ontario Research Fund, Otsuka, Pfizer, Servier, St. Jude Medical, Sunovion, and Xian-Janssen. Dr. Lam has received research funds or honoraria for speaking, advising, or consulting from Akili, Allergan, Asia-Pacific Economic Cooperation, the BC Leading Edge Foundation, Brain Canada, CIHR, the Canadian Depression Research and Intervention Network, the Canadian Network for Mood and Anxiety Treatments, the Canadian Psychiatric Association, the CME Institute, Hansoh, Janssen, Lundbeck, the Lundbeck Institute, Medscape, Mind Mental Health Technologies, Otsuka, Pfizer, St. Jude Medical, the University Health Network Foundation, and the VGH Foundation. Dr. Daskalakis has received research support and in-kind equipment support for an investigator-initiated study through Brainsway and MagVenture. Dr. Blumberger has received research support from Brain Canada, CIHR, NIH, the Weston Brain Institute, and the Temerty Family through the CAMH Foundation and the Campbell Research Institute; he has received research support and in-kind equipment support for an investigator-initiated study from Brainsway and is the site principal investigator for three sponsor-initiated studies for Brainsway; he has received medication supplies for an investigator-initiated trial from Indivior; and he has participated on an advisory board for Janssen. The other authors report no financial relationships with commercial interests.